Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
Diabetes Care|November 5, 1999
Optimized autoantibody-based risk assessment in family members. Implications for future intervention trialsP J Bingley, A J Williams, E A GaleImmunology|February 26, 2000
Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity?A Kretowski, K M Gillespie, P J Bingley, et al.Diabetologia|July 1, 1993
Nicotinamide and insulin secretion in normal subjectsP J Bingley, G Caldas, R Bonfanti, et al.Diabetes Care|May 20, 1999
Capillary whole blood measurement of islet autoantibodiesE Bazzigaluppi, R Bonfanti, P J Bingley, et al.Diabetologia|September 28, 2010
Diabetes Antibody Standardization Program: evaluation of assays for insulin autoantibodiesM Schlosser, P W Mueller, C Törn, et al.Diabetologia|April 1, 2008
Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2C Törn, P W Mueller, M Schlosser, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1988
Trial of ganglioside GM1 in acute strokeB I Hoffbrand, P J Bingley, S M Oppenheimer, et al.Lancet (London, England)|March 27, 2004
European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetesE A M Gale, P J Bingley, C L Emmett, et al.Journal of Autoimmunity|November 7, 1999
Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetesA J Williams, P J Bingley, R E Chance, et al.Pageof 8